Bromodomain Inhibition Reveals FGF15/19 as a Target of Epigenetic Regulation and Metabolic Control

doi 10.1101/2019.12.11.872887

Full Text

Abstract

Available in

Date

Authors

Publisher

Cold Spring Harbor Laboratory

Related search

Identification of Bromodomain-Containing Protein-4 as a Novel Marker and Epigenetic Target in Mast Cell Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2015English

Complement as a Target in COVID-19?

Nature Reviews Immunology
MedicineAllergyImmunology
2020English

FGF15/19 Protein Levels in the Portal Blood Do Not Reflect Changes in the Ileal FGF15/19 or Hepatic CYP7A1 mRNA Levels

Journal of Lipid Research
BiochemistryEndocrinologyCell Biology
2013English

BRCA1 as a Tumor Suppressor Linked to the Regulation of Epigenetic States: Keeping oncomiRs Under Control

Breast Cancer Research
Cancer ResearchOncology
2012English

Epigenetic Inhibition Puts Target Antigen in the Crosshairs of CAR T Cells

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2019English

Irisin: As a Therapeutic Target for Metabolic Disorders

Journal of Endocrinology and Metabolism
EndocrinologyMetabolismDiabetes
2018English

Circadian Control of Bile Acid Synthesis by a KLF15-Fgf15 Axis

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2015English

Dietary Sulforaphane in Cancer Chemoprevention: The Role of Epigenetic Regulation and HDAC Inhibition

Antioxidants and Redox Signaling
Cell BiologyMolecular BiologyBiochemistryClinical BiochemistryMedicinePhysiology
2015English

Pharmacological Inhibition of Bromodomain-Containing Proteins in Inflammation

Cold Spring Harbor perspectives in biology
BiochemistryGeneticsMolecular Biology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy